United States · FDA National Drug Code directory
Sodium Phenylacetate and sodium benzoate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68475-001_e2b1772b-057e-4c1a-a3e1-6bbf7c2d770e
- Product NDC
- 68475-001
- Form
- INJECTION, SOLUTION, CONCENTRATE
- Composition / generic term
- Sodium Phenylacetate and sodium benzoate
- Labeler
- Navinta LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210304
- Source listing expiry
- 20261231
Source-listed ingredients
- SODIUM PHENYLACETATE — 100 mg/mL
- SODIUM BENZOATE — 100 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (68475-001-50) / 50 mL in 1 VIAL · 68475-001-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →